Opinion | The FDA’s damage to medical innovation will be hard to repair

The Washington Post·Feb 18

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

There are concerns about the impact of the FDA's actions on medical innovation. Some outlets suggest that the FDA is experiencing a period of crisis, potentially due to regulatory uncertainty or changes under a previous administration, which may be hindering innovation and posing risks to public health. The extent and causes of the FDA's issues are not clearly defined, with various perspectives on the matter being expressed.

Full coverage

FDA in Crisis: How Trump Administration Downsizing Is Slowing Medical Innovation and Endangering Public Health

American Council on Science and Health·May 1

FDA Oversight: Understanding the Regulation of Health AI Tools

Bipartisan Policy Center·Nov 10

View original report at The Washington Post ↗

Fetching the latest headlines…

Opinion | The FDA’s damage to medical innovation will be hard to repair

Full coverage

Something is very wrong at the FDA

After ‘most damaging period in FDA history,’ Makary will be hard to replace

Opinion: An anti-science FDA is a threat to our health and prosperity

Balancing Innovation and Patient Safety in AI-Powered Medtech

Opinion: Ongoing Regulatory Uncertainty Means Innovation Is Now Higher Risk

Drug and medical device regulation under the Trump administration

FDA in Crisis: How Trump Administration Downsizing Is Slowing Medical Innovation and Endangering Public Health

FDA Oversight: Understanding the Regulation of Health AI Tools